Wockhardt gets nod to raise Rs 1,200 crore via NCDs

31 Aug 2018 Evaluate

Wockhardt has received shareholders’ approval to raise funds of upto Rs 1,200 crore by issuance and allotment of secured/un-secured redeemable Non-Convertible Debentures (NCDs) on private placement basis in one or more tranches.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1176.90 -9.75 (-0.82%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×